0
     

Report Added
Report already added
Next Generation Cancer Diagnostics Market - Global Outlook and Forecast 2022-2028

Next Generation Cancer Diagnostics Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Next Generation Cancer Diagnostics in Global, including the following market information:

Global Next Generation Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Next Generation Cancer Diagnostics market was valued at 6377.6 million in 2021 and is projected to reach US$ 19960 million by 2028, at a CAGR of 17.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Next Generation Sequencing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Next Generation Cancer Diagnostics include Cepheid, Koninklijke Philips N.V, F. Hoffmann-La Roche Ltd, Qiagen, Novartis AG, Abbott, Thermo Fisher Scientific, Opko Health and Myriad Genetics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Next Generation Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Next Generation Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Next Generation Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
Global Next Generation Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Next Generation Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Next Generation Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Next Generation Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next Generation Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Next Generation Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Next Generation Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next Generation Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next Generation Cancer Diagnostics Overall Market Size
2.1 Global Next Generation Cancer Diagnostics Market Size: 2021 VS 2028
2.2 Global Next Generation Cancer Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next Generation Cancer Diagnostics Players in Global Market
3.2 Top Global Next Generation Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Next Generation Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Next Generation Cancer Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Next Generation Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next Generation Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Next Generation Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Next Generation Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Next Generation Cancer Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Next Generation Sequencing
4.1.3 qPCR & Multiplexing
4.1.4 DNA Microarrays
4.1.5 Others
4.2 By Type - Global Next Generation Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Next Generation Cancer Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Next Generation Cancer Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Next Generation Cancer Diagnostics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next Generation Cancer Diagnostics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Next Generation Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Next Generation Cancer Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Next Generation Cancer Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Next Generation Cancer Diagnostics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Next Generation Cancer Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Next Generation Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Next Generation Cancer Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Next Generation Cancer Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Next Generation Cancer Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Next Generation Cancer Diagnostics Revenue, 2017-2028
6.3.2 US Next Generation Cancer Diagnostics Market Size, 2017-2028
6.3.3 Canada Next Generation Cancer Diagnostics Market Size, 2017-2028
6.3.4 Mexico Next Generation Cancer Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Next Generation Cancer Diagnostics Revenue, 2017-2028
6.4.2 Germany Next Generation Cancer Diagnostics Market Size, 2017-2028
6.4.3 France Next Generation Cancer Diagnostics Market Size, 2017-2028
6.4.4 U.K. Next Generation Cancer Diagnostics Market Size, 2017-2028
6.4.5 Italy Next Generation Cancer Diagnostics Market Size, 2017-2028
6.4.6 Russia Next Generation Cancer Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Next Generation Cancer Diagnostics Market Size, 2017-2028
6.4.8 Benelux Next Generation Cancer Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Next Generation Cancer Diagnostics Revenue, 2017-2028
6.5.2 China Next Generation Cancer Diagnostics Market Size, 2017-2028
6.5.3 Japan Next Generation Cancer Diagnostics Market Size, 2017-2028
6.5.4 South Korea Next Generation Cancer Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Next Generation Cancer Diagnostics Market Size, 2017-2028
6.5.6 India Next Generation Cancer Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Next Generation Cancer Diagnostics Revenue, 2017-2028
6.6.2 Brazil Next Generation Cancer Diagnostics Market Size, 2017-2028
6.6.3 Argentina Next Generation Cancer Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next Generation Cancer Diagnostics Revenue, 2017-2028
6.7.2 Turkey Next Generation Cancer Diagnostics Market Size, 2017-2028
6.7.3 Israel Next Generation Cancer Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Next Generation Cancer Diagnostics Market Size, 2017-2028
6.7.5 UAE Next Generation Cancer Diagnostics Market Size, 2017-2028
7 Players Profiles
7.1 Cepheid
7.1.1 Cepheid Corporate Summary
7.1.2 Cepheid Business Overview
7.1.3 Cepheid Next Generation Cancer Diagnostics Major Product Offerings
7.1.4 Cepheid Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Cepheid Key News
7.2 Koninklijke Philips N.V
7.2.1 Koninklijke Philips N.V Corporate Summary
7.2.2 Koninklijke Philips N.V Business Overview
7.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Major Product Offerings
7.2.4 Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Koninklijke Philips N.V Key News
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.3.2 F. Hoffmann-La Roche Ltd Business Overview
7.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.3.5 F. Hoffmann-La Roche Ltd Key News
7.4 Qiagen
7.4.1 Qiagen Corporate Summary
7.4.2 Qiagen Business Overview
7.4.3 Qiagen Next Generation Cancer Diagnostics Major Product Offerings
7.4.4 Qiagen Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Qiagen Key News
7.5 Novartis AG
7.5.1 Novartis AG Corporate Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Next Generation Cancer Diagnostics Major Product Offerings
7.5.4 Novartis AG Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Novartis AG Key News
7.6 Abbott
7.6.1 Abbott Corporate Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Next Generation Cancer Diagnostics Major Product Offerings
7.6.4 Abbott Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.6.5 Abbott Key News
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Corporate Summary
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Major Product Offerings
7.7.4 Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Thermo Fisher Scientific Key News
7.8 Opko Health
7.8.1 Opko Health Corporate Summary
7.8.2 Opko Health Business Overview
7.8.3 Opko Health Next Generation Cancer Diagnostics Major Product Offerings
7.8.4 Opko Health Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.8.5 Opko Health Key News
7.9 Myriad Genetics
7.9.1 Myriad Genetics Corporate Summary
7.9.2 Myriad Genetics Business Overview
7.9.3 Myriad Genetics Next Generation Cancer Diagnostics Major Product Offerings
7.9.4 Myriad Genetics Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.9.5 Myriad Genetics Key News
7.10 Agilent Technologies
7.10.1 Agilent Technologies Corporate Summary
7.10.2 Agilent Technologies Business Overview
7.10.3 Agilent Technologies Next Generation Cancer Diagnostics Major Product Offerings
7.10.4 Agilent Technologies Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.10.5 Agilent Technologies Key News
7.11 GE Healthcare
7.11.1 GE Healthcare Corporate Summary
7.11.2 GE Healthcare Business Overview
7.11.3 GE Healthcare Next Generation Cancer Diagnostics Major Product Offerings
7.11.4 GE Healthcare Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.11.5 GE Healthcare Key News
7.12 PerkinElmer
7.12.1 PerkinElmer Corporate Summary
7.12.2 PerkinElmer Business Overview
7.12.3 PerkinElmer Next Generation Cancer Diagnostics Major Product Offerings
7.12.4 PerkinElmer Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.12.5 PerkinElmer Key News
7.13 Genomic Health
7.13.1 Genomic Health Corporate Summary
7.13.2 Genomic Health Business Overview
7.13.3 Genomic Health Next Generation Cancer Diagnostics Major Product Offerings
7.13.4 Genomic Health Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.13.5 Genomic Health Key News
7.14 Illumina
7.14.1 Illumina Corporate Summary
7.14.2 Illumina Business Overview
7.14.3 Illumina Next Generation Cancer Diagnostics Major Product Offerings
7.14.4 Illumina Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.14.5 Illumina Key News
7.15 Hologic
7.15.1 Hologic Corporate Summary
7.15.2 Hologic Business Overview
7.15.3 Hologic Next Generation Cancer Diagnostics Major Product Offerings
7.15.4 Hologic Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.15.5 Hologic Key News
7.16 Almac Group
7.16.1 Almac Group Corporate Summary
7.16.2 Almac Group Business Overview
7.16.3 Almac Group Next Generation Cancer Diagnostics Major Product Offerings
7.16.4 Almac Group Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.16.5 Almac Group Key News
7.17 Janssen Global Services
7.17.1 Janssen Global Services Corporate Summary
7.17.2 Janssen Global Services Business Overview
7.17.3 Janssen Global Services Next Generation Cancer Diagnostics Major Product Offerings
7.17.4 Janssen Global Services Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.17.5 Janssen Global Services Key News
7.18 Sysmex Corporation
7.18.1 Sysmex Corporation Corporate Summary
7.18.2 Sysmex Corporation Business Overview
7.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Major Product Offerings
7.18.4 Sysmex Corporation Next Generation Cancer Diagnostics Revenue in Global Market (2017-2022)
7.18.5 Sysmex Corporation Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Next Generation Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Next Generation Cancer Diagnostics Market Drivers in Global Market
Table 3. Next Generation Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Next Generation Cancer Diagnostics in Global Market
Table 5. Top Next Generation Cancer Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Next Generation Cancer Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Next Generation Cancer Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Next Generation Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Next Generation Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Next Generation Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Next Generation Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Next Generation Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Next Generation Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Next Generation Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Next Generation Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Next Generation Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Cepheid Corporate Summary
Table 31. Cepheid Next Generation Cancer Diagnostics Product Offerings
Table 32. Cepheid Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Koninklijke Philips N.V Corporate Summary
Table 34. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Offerings
Table 35. Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-La Roche Ltd Corporate Summary
Table 37. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Offerings
Table 38. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Qiagen Corporate Summary
Table 40. Qiagen Next Generation Cancer Diagnostics Product Offerings
Table 41. Qiagen Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Novartis AG Corporate Summary
Table 43. Novartis AG Next Generation Cancer Diagnostics Product Offerings
Table 44. Novartis AG Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Abbott Corporate Summary
Table 46. Abbott Next Generation Cancer Diagnostics Product Offerings
Table 47. Abbott Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Thermo Fisher Scientific Corporate Summary
Table 49. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Offerings
Table 50. Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Opko Health Corporate Summary
Table 52. Opko Health Next Generation Cancer Diagnostics Product Offerings
Table 53. Opko Health Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Myriad Genetics Corporate Summary
Table 55. Myriad Genetics Next Generation Cancer Diagnostics Product Offerings
Table 56. Myriad Genetics Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. Agilent Technologies Corporate Summary
Table 58. Agilent Technologies Next Generation Cancer Diagnostics Product Offerings
Table 59. Agilent Technologies Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. GE Healthcare Corporate Summary
Table 61. GE Healthcare Next Generation Cancer Diagnostics Product Offerings
Table 62. GE Healthcare Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. PerkinElmer Corporate Summary
Table 64. PerkinElmer Next Generation Cancer Diagnostics Product Offerings
Table 65. PerkinElmer Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 66. Genomic Health Corporate Summary
Table 67. Genomic Health Next Generation Cancer Diagnostics Product Offerings
Table 68. Genomic Health Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 69. Illumina Corporate Summary
Table 70. Illumina Next Generation Cancer Diagnostics Product Offerings
Table 71. Illumina Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 72. Hologic Corporate Summary
Table 73. Hologic Next Generation Cancer Diagnostics Product Offerings
Table 74. Hologic Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 75. Almac Group Corporate Summary
Table 76. Almac Group Next Generation Cancer Diagnostics Product Offerings
Table 77. Almac Group Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 78. Janssen Global Services Corporate Summary
Table 79. Janssen Global Services Next Generation Cancer Diagnostics Product Offerings
Table 80. Janssen Global Services Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 81. Sysmex Corporation Corporate Summary
Table 82. Sysmex Corporation Next Generation Cancer Diagnostics Product Offerings
Table 83. Sysmex Corporation Next Generation Cancer Diagnostics Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Next Generation Cancer Diagnostics Segment by Type in 2021
Figure 2. Next Generation Cancer Diagnostics Segment by Application in 2021
Figure 3. Global Next Generation Cancer Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Next Generation Cancer Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Next Generation Cancer Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Next Generation Cancer Diagnostics Revenue in 2021
Figure 8. By Type - Global Next Generation Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Next Generation Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Next Generation Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Next Generation Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Next Generation Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Next Generation Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Next Generation Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Next Generation Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Next Generation Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Cepheid Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Qiagen Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis AG Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Abbott Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Opko Health Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Myriad Genetics Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Agilent Technologies Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. GE Healthcare Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. PerkinElmer Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Genomic Health Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Illumina Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Hologic Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Almac Group Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Janssen Global Services Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Sysmex Corporation Next Generation Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Next Generation Cancer Diagnostics Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW